# A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

> **NCT00787332** · PHASE4 · TERMINATED · sponsor: **Canyon Pharmaceuticals, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Suspected Heparin-Induced Thrombocytopenia

## Interventions

- **DRUG:** Desirudin or Argatroban®

## Key facts

- **NCT ID:** NCT00787332
- **Lead sponsor:** Canyon Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2013-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787332, "A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00787332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*